XENON PHARMACEUTICALS INC. (XENE) Net margin 2016–2025
XENON PHARMACEUTICALS INC. (XENE) net profit margin by fiscal year — reported net income divided by reported revenue.
-4612.1%FY2025 · since FY2016: -1275.5% → -4612.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4612.1% | — |
| FY2022 | -1328.9% | -901.1 pp |
| FY2021 | -427.8% | -338.2 pp |
| FY2020 | -89.7% | +519.4 pp |
| FY2019 | -609.1% | — |
| FY2017 | -9872.7% | -8597.2 pp |
| FY2016 | -1275.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More XENE financial trends
XENE RevenueXENE Net incomeXENE Gross profitXENE Gross marginXENE Operating incomeXENE Operating marginXENE Operating cash flowXENE Free cash flowXENE Capital expendituresXENE Return on equityXENE Stock buybacksXENE Dividends paidXENE Total assetsXENE Total liabilitiesXENE Shareholders’ equityXENE overview →